Home/Filings/4/0001181431-05-004782
4//SEC Filing

Hendrick John T 4

Accession 0001181431-05-004782

CIK 0001042420other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 8:17 PM ET

Size

9.1 KB

Accession

0001181431-05-004782

Insider Transaction Report

Form 4
Period: 2005-01-24
Hendrick John T
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to buy)

    2005-01-24200,000200,000 total
    Exercise: $1.50From: 2004-12-13Exp: 2015-01-24Common Stock (200,000 underlying)
Holdings
  • Common Stock

    46,879
Footnotes (2)
  • [F1]Based on the Company's recommendation to the Board of Directors that the Reporting Person be granted an option to purchase 200,000 shares of the Company's Common Stock at an exercise price of $1.50 per share.
  • [F2]One-fifth of the Shares subject to the option vested as of December 13, 2004 and 1/48th of the remaining Shares shall vest each month thereafter.

Issuer

AKESIS PHARMACEUTICALS, INC.

CIK 0001042420

Entity typeother

Related Parties

1
  • filerCIK 0001312205

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 8:17 PM ET
Size
9.1 KB